Clinical Trials
64 trialsFDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis
Mayo Clinic
GastrExtub
Hospices Civils de Lyon
YASU Research Registry: For Young Adults With Cancer
Young Adult Survivors United
Collection of Outcomes Data for Pregnant Patients With Cancer
M.D. Anderson Cancer Center
A Long-term Follow-up Study of Patients Who Received VOR33
Vor Biopharma
PROXY
AstraZeneca
Connect® Myeloid Disease Registry
Celgene
Blood Samples to Identify Biomarkers of Busulfan
Fred Hutchinson Cancer Center
Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
University of Washington
The clonoSEQ® Watch Registry
Adaptive Biotechnologies
Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
Mustang Bio
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
UNC Lineberger Comprehensive Cancer Center
OMNI
Takeda
Oral Health Condition and Quality of Life in Children With Leukemia
University of Sao Paulo
Dysregulated Tyrosine Kinase Signaling in Leukemia
University of New Mexico
NiiCproject
Nottingham University Hospitals NHS Trust
QPlus Pediatric Reference Interval
HemoSonics LLC
COSMOS
Centre Hospitalier Universitaire de Saint Etienne
Retrospective Evaluation of CML Patients in the National Compassionate Program
Gruppo Italiano Malattie EMatologiche dell'Adulto
AML1617
Gruppo Italiano Malattie EMatologiche dell'Adulto
FIRST
AbbVie
PERDAM
University Hospital Heidelberg
Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy
Fate Therapeutics
Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy
Masonic Cancer Center, University of Minnesota
I-PREDICT Heme
University of California, San Diego
Medical Treatment Decision Making Using Adaptive Conjoint Analysis
St. Jude Children's Research Hospital
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
Jonsson Comprehensive Cancer Center
REAL
SecuraBio
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
Exact Sciences Corporation
Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors
Adaptimmune
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
Juno Therapeutics, a Subsidiary of Celgene
The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia
University of Arkansas
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
N1
CureOne
Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database
Emory University
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Vanderbilt-Ingram Cancer Center
Acute Lymphoblastic Leukemia Registry at Asan Medical Center
Asan Medical Center
Chronic Myelod Leukemia Registry at Asan Medical Center
Asan Medical Center
ATLAS2015
Asan Medical Center
Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
National Institutes of Health Clinical Center (CC)
Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
University of Ulm
Observational Trial of a Therapeutic Platelet Transfusion Regimen
Klinikum Nürnberg
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
OHSU Knight Cancer Institute
Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha
University of Michigan Rogel Cancer Center
Population Pharmacokinetics of Imatinib in CML Patients in Iran
Kerman University of Medical Sciences
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
Stanford University
NADIR
Astellas Pharma Inc
Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)
Stanford University
Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer
Case Comprehensive Cancer Center